Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group Study D9803
- Carola A.S. Arndt
- , Julie A. Stoner
- , Douglas S. Hawkins
- , David A. Rodeberg
- , Andrea A. Hayes-Jordan
- , Charles N. Paidas
- , David M. Parham
- , Lisa A. Teot
- , Moody D. Wharam
- , John C. Breneman
- , Sarah S. Donaldson
- , James R. Anderson
- , William H. Meyer
Producción científica: Article › revisión exhaustiva
346
Citas
(Scopus)